Omega Funds

Omega Funds

Boston, Massachusettsomegafunds.com

Overview

Omega Funds is a venture capital firm based in Boston, Massachusetts, that focuses on healthcare, technology and life science sectors across North America and Europe . They invest in companies across all growth stages in multiple therapeutic areas, including oncology, immunology, rare diseases, and precision medicine .

Year Founded

2004

Portfolio Companies

55

Investments

CompanyDateStageLead
ImmuneBiotechMay 2026Growth EquityCo-investor
Windward BioMay 2026Growth EquityCo-investor
Alveus TherapeuticsFeb 2026Series A ExtensionLead
Third Arc BioFeb 2026Series A ExtensionLead
Caldera TherapeuticsJan 2026Series A ExtensionLead

Key People

Maria Koehler

Venture Partner

Mene Pangalos

Venture Partner

Sanjaya Singh

Venture Partner

Michelle Doig

Partner, Head Of Corporate Development

Vincent Ossipow

Partner

Gilchrist DiPrete

Director, Investor Portfolio Analytics

Sean Cumiskey

Head Of Investor Relations

Mike Powell

Executive Partner Venture Advisor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2004

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.